RU95112464A - Способ получения производных таксана - Google Patents

Способ получения производных таксана

Info

Publication number
RU95112464A
RU95112464A RU95112464/04A RU95112464A RU95112464A RU 95112464 A RU95112464 A RU 95112464A RU 95112464/04 A RU95112464/04 A RU 95112464/04A RU 95112464 A RU95112464 A RU 95112464A RU 95112464 A RU95112464 A RU 95112464A
Authority
RU
Russia
Prior art keywords
ris
formula
hydrogen atom
iii
taxane derivatives
Prior art date
Application number
RU95112464/04A
Other languages
English (en)
Russian (ru)
Inventor
Бурза Жан-Доминик
Fr]
Коммерсон Ален
Депрез Доминик
Пюликани Жан-Пьер
Original Assignee
Рон-Пуленк Роре С.А. (FR)
Рон-Пуленк Роре С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Рон-Пуленк Роре С.А. (FR), Рон-Пуленк Роре С.А. filed Critical Рон-Пуленк Роре С.А. (FR)
Publication of RU95112464A publication Critical patent/RU95112464A/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25B—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
    • C25B3/00—Electrolytic production of organic compounds
    • C25B3/20—Processes
    • C25B3/25—Reduction
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25B—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
    • C25B11/00—Electrodes; Manufacture thereof not otherwise provided for
    • C25B11/04—Electrodes; Manufacture thereof not otherwise provided for characterised by the material
    • C25B11/042—Electrodes formed of a single material
    • C25B11/046—Alloys
    • C—CHEMISTRY; METALLURGY
    • C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25B—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
    • C25B9/00—Cells or assemblies of cells; Constructional parts of cells; Assemblies of constructional parts, e.g. electrode-diaphragm assemblies; Process-related cell features
    • C25B9/17—Cells comprising dimensionally-stable non-movable electrodes; Assemblies of constructional parts thereof
    • C25B9/19—Cells comprising dimensionally-stable non-movable electrodes; Assemblies of constructional parts thereof with diaphragms
    • C25B9/23—Cells comprising dimensionally-stable non-movable electrodes; Assemblies of constructional parts thereof with diaphragms comprising ion-exchange membranes in or on which electrode material is embedded

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Electrochemistry (AREA)
  • Metallurgy (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Electrolytic Production Of Non-Metals, Compounds, Apparatuses Therefor (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
RU95112464/04A 1992-11-12 1993-11-10 Способ получения производных таксана RU95112464A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9213586 1992-11-12
FR9213586A FR2697841B1 (fr) 1992-11-12 1992-11-12 Nouveaux dérivés du taxane, leur préparation et les compositions pharmaceutiques qui les contiennent.

Publications (1)

Publication Number Publication Date
RU95112464A true RU95112464A (ru) 1997-02-20

Family

ID=9435452

Family Applications (1)

Application Number Title Priority Date Filing Date
RU95112464/04A RU95112464A (ru) 1992-11-12 1993-11-10 Способ получения производных таксана

Country Status (15)

Country Link
EP (1) EP0667922A1 (es)
JP (1) JPH08503261A (es)
KR (1) KR950704540A (es)
AU (1) AU5425794A (es)
CA (1) CA2149240A1 (es)
CZ (1) CZ122495A3 (es)
FI (1) FI952294A (es)
FR (1) FR2697841B1 (es)
MX (1) MX9306883A (es)
NO (1) NO951772L (es)
PL (1) PL308957A1 (es)
RU (1) RU95112464A (es)
SK (1) SK60895A3 (es)
WO (1) WO1994011547A1 (es)
ZA (1) ZA938366B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6794523B2 (en) 1991-09-23 2004-09-21 Florida State University Taxanes having t-butoxycarbonyl substituted side-chains and pharmaceutical compositions containing them
FR2710642B1 (fr) * 1993-09-29 1995-11-17 Rhone Poulenc Rorer Sa Nouveaux taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
FR2711369B1 (fr) * 1993-10-20 1995-11-17 Rhone Poulenc Rorer Sa Nouveaux taxoïdes, leur préparation et les compositions qui les contiennent.
US5919815A (en) * 1996-05-22 1999-07-06 Neuromedica, Inc. Taxane compounds and compositions
EP0914116B1 (en) * 1996-05-22 2000-10-11 Protarga Inc. Compositions comprising conjugates of cis-docosahexaenoic acid and taxotere
US5795909A (en) * 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
US7235583B1 (en) 1999-03-09 2007-06-26 Luitpold Pharmaceuticals, Inc., Fatty acid-anticancer conjugates and uses thereof
US8309603B2 (en) 2004-06-07 2012-11-13 University Of Tennessee Research Foundation SARMs and method of use thereof
MXPA06008293A (es) * 2004-01-22 2007-06-11 Univ Miami Formulaciones topicas de coenzima q10 y metodos de uso.
US9889110B2 (en) 2004-06-07 2018-02-13 University Of Tennessee Research Foundation Selective androgen receptor modulator for treating hormone-related conditions
US9884038B2 (en) 2004-06-07 2018-02-06 University Of Tennessee Research Foundation Selective androgen receptor modulator and methods of use thereof
US9730908B2 (en) 2006-08-24 2017-08-15 University Of Tennessee Research Foundation SARMs and method of use thereof
US10010521B2 (en) 2006-08-24 2018-07-03 University Of Tennessee Research Foundation SARMs and method of use thereof
US9844528B2 (en) 2006-08-24 2017-12-19 University Of Tennessee Research Foundation SARMs and method of use thereof
US7968603B2 (en) 2007-09-11 2011-06-28 University Of Tennessee Research Foundation Solid forms of selective androgen receptor modulators
EA201101522A1 (ru) 2009-05-11 2012-09-28 БЕРГ БАЙОСИСТЕМЗ, ЭлЭлСи Способы лечения болезней с использованием эпиметаболического переключателя (коэнзим q10)
EP2694463B8 (en) 2011-04-04 2019-10-09 Berg LLC Treating central nervous system tumors with coenzyme q10
US9622992B2 (en) 2012-07-13 2017-04-18 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
US10258596B2 (en) 2012-07-13 2019-04-16 Gtx, Inc. Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
US9744149B2 (en) 2012-07-13 2017-08-29 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
WO2014168993A1 (en) 2013-04-08 2014-10-16 Berg Llc Treatment of cancer using coenzyme q10 combination therapies
WO2015035094A1 (en) 2013-09-04 2015-03-12 Berg Llc Methods of treatment of cancer by continuous infusion of coenzyme q10

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
NO951772D0 (no) 1995-05-05
FI952294A0 (fi) 1995-05-11
CZ122495A3 (en) 1995-12-13
KR950704540A (ko) 1995-11-20
FR2697841B1 (fr) 1995-01-13
CA2149240A1 (fr) 1994-05-26
SK60895A3 (en) 1996-03-06
MX9306883A (es) 1995-01-31
ZA938366B (en) 1994-06-13
WO1994011547A1 (fr) 1994-05-26
FR2697841A1 (fr) 1994-05-13
PL308957A1 (en) 1995-09-04
EP0667922A1 (fr) 1995-08-23
NO951772L (no) 1995-05-05
FI952294A (fi) 1995-05-11
JPH08503261A (ja) 1996-04-09
AU5425794A (en) 1994-06-08

Similar Documents

Publication Publication Date Title
RU95112464A (ru) Способ получения производных таксана
CA2150944A1 (fr) Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
KR910011887A (ko) 신규 a-노르-스테로이드-3-카르복실산 유도체
GEP19981299B (en) Method of Preparing Taxane Derivatives
ATE141920T1 (de) Verfahren zur herstellung von taxan-derivaten
NO953452D0 (no) Nye taxoider, deres fremstilling og farmasöytiske preparater inneholdende forbindelsene
RU94041682A (ru) Способ получения производных таксана
AU2309695A (en) Process for preparing 7-trialkylsilyl baccatin iii
DE3280255D1 (de) Herstellung von substituierten gamma-butyrolactonen, verwendbar als zwischenprodukte zur herstellung von fungiziden imidazolen und triazolen.
PT79724A (en) Chemical synthesis
ATE30718T1 (de) Herstellung von 1-benzyl azetidin-3-ol und von dem entsprechenden halid acid.
RU95113420A (ru) Способы получения 1,3-оксазолидин-5-карбоновой кислоты